Precigen, Inc.

Filed a patent for "cd19-targeted car t cell therapy" on Mon, July 31, 2023

Filed a patent for "cd19-targeted car t cell therapy" on Mon, March 18, 2024

Filed a patent for "therapy for alpha-1 antitrypsin deficiency" on Mon, July 10, 2023

Filed a patent for "t cell receptors generated as a result of hpv vaccine therapy and methods of treating patients with same" on Mon, May 22, 2023

Filed a patent for "novel adenovirus vaccine therapy for the treatment of recurrent respiratory papillomatosis" on Mon, May 22, 2023

Filed a patent for "human papillomavirus vaccines and uses of the same" on Mon, May 22, 2023

Filed a patent for "human papilloma virus vaccines and uses of the same for hpv associated diseases" on Thu, May 30, 2024

Filed a patent for "frataxin expression constructs" on Thu, January 4, 2024

Filed a patent for "polycistronic mirna constructs for immune checkpoint inhibition" on Sun, July 10, 2022